Anbio Spearheads “Point of Care” Diagnostic Revolution in Europe

Latest Comments
No comments to show.

Tags:

Anbio Biotechnology is set to revolutionise the European healthcare sector with the AF-100 C, its flagship compact fluorescent immunoassay analyzer. This cutting-edge device, capable of conducting over 70 assays, promises to elevate patient care and diagnostic precision within the EU healthcare framework. Anbio Biotechnology (Anbio), renowned for its leadership in vitro diagnostics…

Source

Categories

No responses yet

Leave a Reply

Your email address will not be published.